Evidence map›Paper›PMID 29167758›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2017

High-throughput microarray for antimicrobial susceptibility testing.

Anand Srinivasan, Grace C Lee, Nelson S Torres, Kevin Hernandez, Steven D Dallas, Jose Lopez-Ribot, Christopher R Frei, Anand K Ramasubramanian

Abstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anand SrinivasanDepartment of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, 78249, United States.
Grace C LeeCollege of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, United States.
Nelson S TorresDepartment of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, 78249, United States.
Kevin HernandezDepartment of Biomedical, Chemical and Materials Engineering, San José State University, San José, CA, 95192, United States.
Steven D DallasDepartment of Pathology, School of Medicine, The University of Texas Health Science Center, San Antonio, TX, 78229, United States.
Jose Lopez-RibotDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, 78249, United States.
Christopher R FreiCollege of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, United States.
Anand K RamasubramanianDepartment of Biomedical, Chemical and Materials Engineering, San José State University, San José, CA, 95192, United States.

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthTL1TR001119 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$640k
NCATS NIH HHS KL2 TR001118NCATS NIH HHS TL1 TR001119NCATS NIH HHS UL1 TR001120NIDCR NIH HHS R01 DE023510
6 · The paper itself

Abstract

We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip for culturing community acquired methicillin resistant

Indexed as

Antimicrobial susceptibility testingHigh-throughputMicroarray

Identifiers

PMID29167758
PMCPMC5686425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.